Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1355 of 5804
-
New pill targets rare cancer gene in early trial
Disease control Recruiting nowThe study is being conducted to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of 3HP-2827 in the treatment of unresectable or metastatic solid tumors with FGFR2 alterations.
Phase: PHASE1, PHASE2 • Sponsor: 3H (Suzhou) Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New community program helps High-Risk COPD patients take control of their health
Disease control CompletedStudy Participants: High-risk COPD population, defined as individuals whose score of COPD-SQ is 16 and above and whose age is 35 and above. COPD-SQ questionnaire will be assigned to a representative sample of local residents in Xishui County, and they will finish the questionnair…
Phase: NA • Sponsor: Peking Union Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo inhaler aims to cut severe asthma attacks in half
Disease control Recruiting nowAn event-driven, Phase III study to evaluate the efficacy and safety of BDA MDI compared with AS MDI in reducing the risk of a severe asthma exacerbation in symptomatic Chinese adults with asthma.
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy targets hard-to-treat pancreatic cancer
Disease control Recruiting nowThe study is being conducted to evaluate the safety, tolerability and efficacy of HRS-4642 combined with adebrelimab, or with adebrelimab and other antitumor agents in patients with advanced pancreatic ductal adenocarcinoma (PDAC).
Phase: PHASE1, PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Stroke recovery boost: extra Arm-Hand training shows promise
Symptom relief Recruiting nowThe overall aim of this study is to establish the clinical- and cost-effectiveness of the arm-hand BOOST therapy when delivered on top of the usual care program in the sub-acute phase post stroke and to perform a process evaluation. In this phase III RCT, 80 patients with stroke…
Phase: NA • Sponsor: KU Leuven • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Drug-Releasing implant aims to boost hearing for adults with severe loss
Symptom relief CompletedThis clinical study will test a newly developed cochlear implant known as CI622D. This experimental cochlear implant has been designed to slowly release a drug called dexamethasone. Dexamethasone works to ease inflammation, which is common after any surgical procedure. The goal i…
Phase: NA • Sponsor: Cochlear • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Koselugo under the microscope: Real-World data on nerve tumor drug
Disease control Recruiting nowAs part of a post-approval commitment, the Korean health authority requests a study to characterize safety and effectiveness in patients treated with Koselugo (Selumetinib), an oral selective inhibitor of MAPK kinase (MEK) 1 and 2, by physicians in routine clinical practice setti…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Real-World data shows High-Dose tafamidis may slow nerve damage in ATTR-CM patients
Disease control CompletedThis study will examine the clinical effectiveness of Tafamidis in patients with Mixed Phenotype Transthyretin Amyloidosis using data that already exist in patients' medical records
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for back pain: higher dose of secukinumab tested in chinese ankylosing spondylitis patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of secukinumab 300mg in Chinese adults participants with active ankylosing spondylitis (AS) who have had an inadequate response to at least 2 non-steroidal anti-inflammatory drugs (NSAIDs) or intolerance to or a con…
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Diabetes drug repurposed to fight polycystic kidney disease
Disease control OngoingThe EMPA-PKD trial is assessing the safety of empagliflozin in patients with rapid progressive ADPKD with and without concomitant tolvaptan use by monitoring kidney growth and the rate of loss of kidney function.
Phase: PHASE4 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could magnetic pulses to the brain help mothers bond better?
Disease control CompletedObjective: To evaluate the overall efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of maternal care impairment (MCI) and to explore the central mechanism of rTMS for MCI. Design: Combined functional magnetic resonance imaging (fMRI) with Maternal…
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gardening to fight HIV: new study plants hope for better health
Disease control OngoingThe investigators are conducting a fully powered cluster randomized controlled trial (RCT) of a culturally appropriate, multicomponent intervention combining peer nutritional counseling with urban gardening among people with human immunodeficiency virus (HIV) in the Dominican Rep…
Phase: NA • Sponsor: University of Massachusetts, Amherst • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a smartphone help silence distressing voices? online self-help program tested for psychosis
Symptom relief CompletedThe proposed clinical trial aims to examine the efficacy of an online-based self-help intervention for auditory hallucinations in persons with psychotic disorders. The intervention is primarily based on Metacognitive Training (MKT) and Mindfulness-Based Group Therapy (MBGT). The …
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
AI-Powered ECG could spot silent heart weakness before It's too late
Diagnosis TerminatedA prospective, cluster-randomized, care-as-usual controlled trial to evaluate the impact of an ECG-based artificial intelligence (ECG-AI) algorithm to detect low left ventricular ejection fraction (LVEF) on diagnosis rates of LVEF ≤ 40% in the outpatient setting. The objective o…
Phase: NA • Sponsor: Anumana, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 13:27 UTC
-
New blood test may spot hidden tumors in MEN1 patients
Diagnosis Recruiting nowMultiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disease with a high degree of penetrance (\>80% of patients). It is caused by the presence of the MEN1 mutation located on chromosome 11q13. The prevalence of this mutation is estimated at approximately 1/30,000.…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo targets rare bladder cancer
Disease control Recruiting nowBackground: Small cell carcinoma of the bladder (SCCB) and other high-grade neuroendocrine tumors (HGNET) of the urinary tract are rare but aggressive cancers. Average survival for people diagnosed with SCCB or HGNET is about 1 year. Lurbinectedin and avelumab are drugs that are…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Shocking the tongue to fix balance? new trial tests PoNS device in stroke patients
Disease control OngoingDouble blind, randomized, placebo controlled, interventional clinical trial investigating the efficacy and safety of PoNS therapy on improving dynamic gait and balance deficits in chronic stroke survivors.
Phase: NA • Sponsor: Helius Medical Inc • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Free meals and coaching aim to cut pregnancy risks
Prevention OngoingThe goal of this study is to learn whether access to healthy and fresh food, health coaching, and nutrition support intervention can reduce adverse birth outcomes in pregnant women. The main questions it aims to answer are: * Does access to healthy and fresh food, health coachin…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Probiotic capsules take on bacterial vaginosis in major trial
Disease control CompletedPrimary Objective: To confirm that the clinical cure rate of Vaginal Lactobacillus Dual Probiotic Capsules for bacterial vaginosis (BV) is superior to placebo at the 21-30 day post-treatment visit (Day 21 to Day 30). Key Secondary Objective: To compare the clinical cure rate of …
Phase: PHASE3 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for lung cancer: first human trial of DZD6008 begins
Disease control Recruiting nowThis study is designed to evaluate safety and antitumor activity of DZD6008 in patients with advanced NSCLC with EGFR mutations. This is the first time the drug is tested in human.
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC